Home > Quotes > GSK

GlaxoSmithKline PLC Stock Quote & Summary Data

Get GSK Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
1 Year Target 48.04
Today's High /Low "Today's High" The highest sales price the stock has achieved during the regular trading hours, the intra-day high.
"Today's Low" The lowest sales price the stock has fallen to during the regular trading hours, the intra-day low.
Share Volume "Share Volume" is the number of shares of the stock traded on the listing exchange during current trading hours. It does not include after hours volume.
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 4,096,586
Previous Close "Previous Close" is the previous trading day's last reported trade price during official trading hours. $ 47.84
52 Week High/Low "52 Week High" is the highest sales price the stock has achieved during the regular trading hours during the most recent 52 week period.
"52 Week Low" is the lowest sales price the stock has fallen to during the regular trading hours during the most recent 52 week period.
$ 56.60 / $ 41.25
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 113,902,840,000
P/E Ratio "P/E Ratio" is a statistic calculated by dividing the price of a stock by the reported actual earnings per share of the issuing firm (not the same as the projected P/E ratio); it is also called the "multiple". 25.91
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 16.79
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 1.83
Annualized dividend $ 2.781
Ex Dividend Date Feb. 18, 2015
Dividend Payment Date Apr. 9, 2015
Current Yield Indicated yield represents annual dividends divided by current stock price. 5.81 %
Beta "Beta" is a volatility measurement of a stock mutual fund or ETF versus a comparable benchmark like the S&P 500 stock index. A stock fund or ETF with a higher beta than the S&P 500 will rise or fall to a greater degree. In contrast, a stock fund or ETF with a low beta will rise or fall less. 0.71

Intraday Chart

ETFs with GSK as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
5.18% Market Vectors Pharmaceutical ETF (PPH) +6.99  (11.19%)
1.97% FlexShares Ready Access Variable Income Fund (RAVI) -0.17  (-0.22%)
1.69% iShares iBonds Mar 2016 Corporate ex-Financials Term ETF (IBCB) +0.22  (0.22%)
1.28% ALPS STOXX Europe 600 ETF (STXX) N/A  (N/A)
0.62% iShares iBonds Mar 2016 Corporate ETF (IBDA) +0.02  (0.02%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

* "Our CEO's Review of the year" on pages 4 and 5 (excluding the information in the first paragraph under the heading "Outlook" on page 5); * "Business overview" on pages 6 and 7 * "The global context" on pages 8 to 11; * "Our business model" on pages 12 and 13; * "Our strategic priorities " on pages 14 and 15, (excluding the information in the first paragraph under the heading "Outlook" on page 15); * "How we performed" on pages 16 and 17; * "Risk management," "Global risk management" and "Risk management within the business" on pages 18 and 19; * "Deliver" on pages 32 and 33; * "Pipeline progress" o  ... More ...  

Risk Grade

Where does GSK fit in the risk graph?

Risk Grade Scale

News for GSK

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?